Executive officer changes to be effective as of October 1, 2026. Masataka Shouji will assume Senior Executive Officer in charge of Domestic Healthcare and V&S_EVS businesses, and concurrently serve as Head of Development Division and Development Planning Manager. Masaki Kita will be an Executive Officer overseeing Global Development and the Imaging Technology Development Department. Minoru Kontani will be a Director and Executive Officer responsible for Global Business Management and Public Relations.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6737","jir_company_name":"EIZO Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/6737-20260911-01.pdf","jir_short_summary":"Executive officer changes to be effective as of October 1, 2026. Masataka Shouji will assume Senior Executive Officer in charge of Domestic Healthcare and V&S_EVS businesses, and concurrently serve as Head of Development Division and Development Planning Manager. Masaki Kita will be an Executive Officer overseeing Global Development and the Imaging Technology Development Department. Minoru Kontani will be a Director and Executive Officer responsible for Global Business Management and Public Relations.","jir_summary":"### Overview of the personnel changes\nThe announced personnel changes include the executive officer appointments effective October 1, 2026, with Masataka Shouji as Senior Executive Officer overseeing the Domestic Healthcare and V&S_EVS businesses, while also serving as Head of the Development Division and Development Planning Manager. Masaki Kita will serve as Executive Officer overseeing Global Development and the Imaging Technology Development Department, and Minoru Kontani will serve as Director and Executive Officer responsible for Global Business Management and Public Relations, as well as overseeing the European sales subsidiaries\/agents.\n\n### Impact and future strategy\nThe leadership refresh strengthens the oversight of domestic healthcare, imaging technology, and global expansion. Under the leadership of the new executives, there is potential acceleration of integration between development and global businesses and expansion into overseas markets. Although specific numerical impacts on performance are not disclosed, organizational changes are expected to contribute to mid- to long-term business advancement.","jir_financial_highlights":"Unspecified: Unspecified (Unspecified)","jir_category":"","jir_hashtags":"#EIZOCorporationExecutiveAppointments, No treasury stock acquisitions or dividends, Strengthening overseas expansion","jir_key_figures":"Executive officer appointments (effective October 1, 2026)\nMasataka Shouji: Senior Executive Officer, Domestic Healthcare & V&S_EVS, Head of Development Division and Development Planning Manager\nMasaki Kita: Executive Officer, Global Development, Head of Imaging Technology Development, Head of Imaging System Development\nMinoru Kontani: Director, Global Business Management & Public Relations, Executive Officer overseeing European subsidiaries\/agents","jir_meta_title":"EIZO Corporation Announces Executive Appointments | Taking Effect October 1, 2026","jir_meta_description":"EIZO will implement executive officer changes effective October 1, 2026. Masataka Shouji will become Senior Executive Officer, Masaki Kita will become Executive Officer, and Minoru Kontani will become Director and Executive Officer. The organizational enhancements aim to accelerate business advancement domestically and internationally.","jir_og_title":"EIZO Corporation Announces Executive Appointments | Taking Effect October 1, 2026","jir_og_description":"EIZO announces executive officer changes. Confirm the new roles and start dates for Masataka Shouji, Masaki Kita, and Minoru Kontani.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9640,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-113206","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n